OMEROS CORP Long-Term Debt
OMEROS CORP (OMER) had Long-Term Debt of $131.69 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2018-11-08
- 2018-09-30: Long-term Debt, Excluding Current Maturities $131.69M.
- 2018-06-30: Long-term Debt, Excluding Current Maturities $129.75M.
- 2018-03-31: Long-term Debt, Excluding Current Maturities $85.04M.
- 2017-12-31: Long-term Debt, Excluding Current Maturities $84.12M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2018-09-30 | $131.69M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $129.75M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $85.04M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $84.12M 10-Q · filed 2018-11-08 | |
| 2017-09-30 | $82.78M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $81.51M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $80.50M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $79.51M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $70.29M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $69.83M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $49.97M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $49.77M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $18.97M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $21.48M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $23.91M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $26.12M 10-K · filed 2016-03-15 | $26.26M 10-K · filed 2015-03-16 |
| 2014-09-30 | $28.55M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $30.76M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $32.21M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $14.90M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $16.38M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $17.81M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $19.20M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $20.10M 10-K · filed 2014-03-13 | |
| 2011-12-31 | $13.55M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |